{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:39:29Z","timestamp":1790368769328,"version":"4.1.0"},"publisher-location":"Chichester, UK","reference-count":224,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004143.pub4","type":"reference-entry","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T19:24:49Z","timestamp":1341602689000},"source":"Crossref","is-referenced-by-count":94,"title":["Long term hormone therapy for perimenopausal and postmenopausal women"],"prefix":"10.1002","author":[{"given":"Jane","family":"Marjoribanks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Farquhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lethaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,7,11]]},"reference":[{"key":"10.1002\/14651858.CD004143.pub4-BIB1|cit1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1200\/JCO.2005.02.8464","article-title":"Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group study","volume":"24","author":"Barakat","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB2|cit2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.7326\/0003-4819-135-11-200112040-00005","article-title":"Estrogen in the prevention of atherosclerosis: a randomized, double-blind, placebo-controlled trial","volume":"135","author":"Hodis","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub4-BIB3|cit3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/01.GME.0000153934.76086.A4","article-title":"Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atheroscerosis Trial","volume":"12","author":"Karim","year":"2005","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD004143.pub4-BIB4|cit4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6874-8-5","article-title":"Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial","volume":"8","author":"Veerus","year":"2010","journal-title":"BMC Women's Health"},{"key":"10.1002\/14651858.CD004143.pub4-BIB5|cit5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.maturitas.2006.01.012","article-title":"Results from the Estonian postmenopausal hormone therapy trial (IRSRCTN35338757)","volume":"55","author":"Veerus","year":"2006","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD004143.pub4-BIB6|cit6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.maturitas.2005.05.001","article-title":"Treatment adherence in the Estonian postmenopausal hormone therapy (EPHT) trial (ISRCTN35339757)","volume":"52","author":"Vorobjov","year":"2005","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD004143.pub4-BIB7|cit7","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1056\/NEJM200008243430801","article-title":"Effects of oestrogen replacement on the progression of coronary artery atherosclerosis","volume":"343","author":"Herrington","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004143.pub4-BIB8|cit8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0197-2456(00)00054-4","article-title":"The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort","volume":"21","author":"Herrington","year":"2000","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD004143.pub4-BIB9|cit9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/13697130008500132","article-title":"The ERA trial: findings and implications for the future","volume":"3","author":"Nair","year":"2000","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD004143.pub4-BIB10|cit10","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0140-6736(02)12001-0","article-title":"Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004143.pub4-BIB11|cit11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1046\/j.1365-2141.2001.03111.x","article-title":"Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial","volume":"115","author":"Hoibraaten","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB12|cit12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1055\/s-0037-1615717","article-title":"The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism - Results from a randomized, double-blind, clinical trial","volume":"85","author":"Hoibraaten","year":"2001","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004143.pub4-BIB13|cit13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1055\/s-0037-1614156","article-title":"Increased risk of recurrent venous thromboembolism during hormone replacement therapy","volume":"84","author":"Hoibraaten","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD004143.pub4-BIB14|cit14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/cmt.5.1.26.35","article-title":"Endometrial safety and bleeding patterns during a 2-year study of 1 or 2 mg 17 Beta-estradiol combined with sequential 5-20 mg dydrogesterone","volume":"5","author":"Ferenczy","year":"2002","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD004143.pub4-BIB15|cit15","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.amjmed.2005.03.004","article-title":"The effect of hormone replacement on physical performance in community-dwelling elderly women","volume":"118","author":"Greenspan","year":"2005","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD004143.pub4-BIB16|cit16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0378-5122(02)00340-7","article-title":"A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being and quality of life in postmenopausal Chinsese women","volume":"44","author":"Haines","year":"2003","journal-title":"Maturitas"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB17|cit17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.amjcard.2004.09.021","article-title":"Effect of hormone therapy among women with heart failure and coronary artery disease","volume":"95","author":"Bibbins-Domingo","year":"2005","journal-title":"The American Journal of Cardiology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB18|cit18","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1161\/01.ATV.0000033514.79653.04","article-title":"Effect of oestrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease","volume":"22","author":"Byington","year":"2002","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB19|cit19","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0197-2456(98)00010-5","article-title":"Heart and Estrogen\/progestin Replacement Study (HERS): design, methods and baseline characteristics","volume":"19","author":"Grady","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub4-BIB20|cit20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6.8 years of hormone therapy","volume":"288","author":"Grady","year":"2002","journal-title":"Journal of the American Medical Association"},{"issue":"9","key":"10.1002\/14651858.CD004143.pub4-BIB21|cit21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.7326\/0003-4819-132-9-200005020-00002","article-title":"Postmenopausal hormone therapy increases risk for venous thromboembolic disease","volume":"132","author":"Grady","year":"2000","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub4-BIB22|cit22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0002-9343(02)01270-6","article-title":"Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen\/progestin Replacement Study","volume":"113","author":"Grady","year":"2002","journal-title":"Americal Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub4-BIB23|cit23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0002-8703(98)70191-7","article-title":"Comparison of the Heart and Oestrogen Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III)","volume":"136","author":"Herrington","year":"1998","journal-title":"American Heart Journal"},{"issue":"25","key":"10.1002\/14651858.CD004143.pub4-BIB24|cit24","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1161\/01.CIR.0000019406.74017.B2","article-title":"Statin therapy, cardiovascular events and total mortality in the Heart and Estrogen\/progestin Replacement Study (HERS)","volume":"105","author":"Herrington","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub4-BIB25|cit25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1001\/jama.287.5.591","article-title":"Quality of life and depressive symptoms in postmenopausal women after receiving hormone therapy","volume":"287","author":"Hlatky","year":"2002","journal-title":"Journal of American Medical Association"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub4-BIB26|cit26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jama.288.1.58","article-title":"Noncardiovascular disease outcomes during 6.8 years of hormone therapy","volume":"288","author":"Hulley","year":"2002","journal-title":"Journal of the American Medical Association"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub4-BIB27|cit27","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB28|cit28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-138-1-200301070-00005","article-title":"Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen\/progestin Replacement study","volume":"138","author":"Kanaya","year":"2003","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004143.pub4-BIB29|cit29","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0002-9149(03)00121-8","article-title":"Effect of postmenopausal hormone therapy on coronary heart disease events after percutaneous transluminal coronary angioplasty","volume":"91","author":"Khan","year":"2003","journal-title":"The American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub4-BIB30|cit30","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/01.CIR.103.5.638","article-title":"Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS)","volume":"103","author":"Simon","year":"2001","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD004143.pub4-BIB31|cit31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7326\/0003-4819-135-7-200110020-00008","article-title":"Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease","volume":"135","author":"Simon","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004143.pub4-BIB32|cit32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7326\/0003-4819-138-2-200301210-00007","article-title":"Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen\/progestin Replacement Study","volume":"138","author":"Vittinghoff","year":"2003","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004143.pub4-BIB33|cit33","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jama.283.8.1007","article-title":"Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial","volume":"283(8)","author":"Mulnard","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub4-BIB34|cit34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/00006250-197907000-00017","article-title":"Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems","volume":"54","author":"Nachtigall","year":"1979","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB35|cit35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.maturitas.2005.04.003","article-title":"Pulsed estrogen therapy improves postmenopausal quality of life: A 2-year placebo-controlled study","volume":"53","author":"Nielsen","year":"2006","journal-title":"Maturitas"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB36|cit36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s00198-003-1535-8","article-title":"Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study","volume":"15","author":"Nielsen","year":"2004","journal-title":"Osteoporosis International"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub4-BIB37|cit37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00042192-200209000-00007","article-title":"Effectiveness of Alora estradiol matrix transdermal delivery system in improving lumbar bone mineral density in health, postmenopausal women","volume":"9","author":"Notelovitz","year":"2002","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD004143.pub4-BIB39|cit38","unstructured":"Bech P Personal communication with J.Marjoribanks"},{"key":"10.1002\/14651858.CD004143.pub4-BIB38|cit39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000012289","article-title":"Combined versus sequential hormonal replacement therapy: a double blind placebo-controlled study on quality of life-related measures","volume":"67","author":"Bech","year":"1998","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1002\/14651858.CD004143.pub4-BIB40|cit40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0378-5122(93)90129-6","article-title":"A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment","volume":"16","author":"Obel","year":"1993","journal-title":"Maturitas"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub4-BIB41|cit41","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1532-5415.2007.01085.x","article-title":"The effect of 3-year treatment with 0.25 mg\/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women","volume":"55","author":"Pefanco","year":"2007","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD004143.pub4-BIB42|cit42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0378-5122(97)00041-8","article-title":"The postmenopausal estrogen\/progestin interventions study: primary outcomes in adherent women","volume":"27","author":"Barrett-Connor","year":"1997","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD004143.pub4-BIB43|cit43","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/01.CIR.100.7.717","article-title":"Effect of postmenopausal hormones on inflammation-sensitive proteins","volume":"100","author":"Cushman","year":"1999","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD004143.pub4-BIB44|cit44","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1016\/0197-2456(94)00033-Y","article-title":"Rationale, design and conduct of the PEPI trial","volume":"16","author":"Espeland","year":"1995","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub4-BIB45|cit45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/jnci\/95.1.30","article-title":"Postmenopausal hormone therapy and change in mammographic density","volume":"951","author":"Greendale","year":"2003","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD004143.pub4-BIB46|cit46","first-page":"853","article-title":"Bleeding patterns of the hormone replacement therapies in the postmenopausal estrogen and progestin interventions trial","volume":"100","author":"Lindenfeld","year":"2002","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB47|cit47","doi-asserted-by":"publisher","first-page":"54S","DOI":"10.1016\/0197-2456(94)00113-H","article-title":"Baseline characteristics of the PEPI particpants","volume":"16","author":"Miller","year":"1995","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub4-BIB48|cit48","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3109\/13697139809085538","article-title":"Effect of hormone replacement therapy on self-reported cognitive symptoms: results from the Postmenopausal Estrogen\/Progestin Interventions (PEPI) trial","volume":"13","author":"Reboussin","year":"1998","journal-title":"Climacteric"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB49|cit49","first-page":"211","article-title":"The postmenopausal estrogen-progestin interventions (PEPI) trial","volume":"10","author":"Stefanick","year":"1999","journal-title":"Infertility and Reproductive Clinics of North America"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub4-BIB50|cit50","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/jama.1996.03530290040035","article-title":"Effects of hormone replacement therapy on endometrial histology in postmenopausal women","volume":"275","year":"1996","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub4-BIB51|cit51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women","volume":"273","year":"1995","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub4-BIB52|cit52","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.psyneuen.2009.02.009","article-title":"A randomized double-blind trial of the effects of hormone therapy on delayed verbal recall in older women","volume":"34","author":"Tierney","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB53|cit53","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ahj.2004.01.025","article-title":"Remnant-like lipoproteins, hormone therapy and angiographic and clinical outcomes: The Women's Angiographic Vitamin and Estrogen trial","volume":"147","author":"Bittner","year":"2004","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD004143.pub4-BIB54|cit54","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S0197-2456(02)00237-4","article-title":"Women's angiographic vitamin and estrogen trial: design and methods","volume":"23","author":"Hsia","year":"2002","journal-title":"Controlled Clinical Trials"},{"issue":"19","key":"10.1002\/14651858.CD004143.pub4-BIB55|cit55","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1001\/jama.288.19.2432","article-title":"Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women","volume":"288","author":"Waters","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub4-BIB56|cit56","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1052-3057(98)80026-8","article-title":"Estrogen after ischemic stroke: Clinical basis and design of the women's estrogen for stroke trial","volume":"7","author":"Kernan","year":"1998","journal-title":"Journal of Stroke and Cardiovascular Diseases"},{"key":"10.1002\/14651858.CD004143.pub4-BIB57|cit57","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","article-title":"Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy","volume":"295","author":"Stefanick","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB58|cit58","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ajog.2004.08.017","article-title":"Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST)","volume":"192","author":"Viscoli","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"17","key":"10.1002\/14651858.CD004143.pub4-BIB59|cit59","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1056\/NEJMoa010534","article-title":"A clinical trial of estrogen-replacement therapy after ischemic stroke","volume":"345","author":"Viscoli","year":"2001","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004143.pub4-BIB60|cit60","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.maturitas.2006.05.004","article-title":"Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin","volume":"55","author":"Anderson","year":"2006","journal-title":"Maturitas"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub4-BIB61|cit61","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":"Effects of Estrogen plus progestin on gynecologic cancers and associated diagnostic procedures","volume":"290","author":"Anderson","year":"2003","journal-title":"Journal of the American Medical Association"},{"issue":"5 Part 1","key":"10.1002\/14651858.CD004143.pub4-BIB62|cit62","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/01.AOG.0000158120.47542.18","article-title":"Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative","volume":"105","author":"Barnabei","year":"2005","journal-title":"Obsterics and Gynecology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB63|cit63","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1001\/archinte.165.17.1976","article-title":"Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy","volume":"165","author":"Brunner","year":"2005","journal-title":"Archives of Internal Medicine"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub4-BIB64|cit64","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density","volume":"290","author":"Cauley","year":"2003","journal-title":"Journal of the American Medical Association"},{"issue":"18","key":"10.1002\/14651858.CD004143.pub4-BIB65|cit65","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/jnci\/djq285","article-title":"Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial","volume":"102","author":"Chlebowski","year":"2010","journal-title":"Journal of the National Cancer Institute"},{"issue":"24","key":"10.1002\/14651858.CD004143.pub4-BIB66|cit66","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB67|cit67","first-page":"360","article-title":"Breast cancer after use of estrogen plus progestin in postmenopausal women","volume":"6","author":"Chlebowski","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"9697","key":"10.1002\/14651858.CD004143.pub4-BIB68|cit68","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0140-6736(09)61526-9","article-title":"Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial","volume":"374","author":"Chlebowski","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD004143.pub4-BIB69|cit69","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa032071","article-title":"Estrogen plus progestin and colorectal cancer in postmenopausal women","volume":"350","author":"Chlebowski","year":"2004","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub4-BIB70|cit70","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/jama.293.3.330","article-title":"Effect of estrogen therapy on gallbladder disease","volume":"293","author":"Cirillo","year":"2005","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB71|cit71","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/archinte.166.7.772","article-title":"Venous thrombosis and conjugated equine estrogen in women without a uterus","volume":"166","author":"Curb","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub4-BIB72|cit72","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub4-BIB73|cit73","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1532-5415.2010.02953.x","article-title":"Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: Results from the Women's Health Initiative study of cognitive aging extension","volume":"58","author":"Espeland","year":"2010","journal-title":"Journal of the American Geriatrics Society"},{"issue":"24","key":"10.1002\/14651858.CD004143.pub4-BIB74|cit74","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1001\/jama.291.24.2959","article-title":"Conjugated equine estrogens and global cognitive function in postmenopausal women","volume":"291","author":"Espeland","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB75|cit75","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/S1047-2797(03)00042-5","article-title":"The Women's Health Initiative recruitment methods and results","volume":"13","author":"Hays","year":"2003","journal-title":"Annals of Epidemiology"},{"issue":"19","key":"10.1002\/14651858.CD004143.pub4-BIB76|cit76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJMoa030311","article-title":"Effects of estrogen plus progestin on health-related quality of life","volume":"348","author":"Hays","year":"2003","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD004143.pub4-BIB77|cit77","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1001\/jama.299.9.1036","article-title":"Health risks and benefit 3 years after stopping randomized treatment with estrogen and progestin","volume":"299","author":"Heiss","year":"2008","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB78|cit78","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1161\/CIRCULATIONAHA.105.594077","article-title":"Effects of conjugated equine estrogen on stroke in the Women's Health Initiative","volume":"113","author":"Hendrix","year":"2006","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD004143.pub4-BIB79|cit79","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1001\/archinte.166.3.357","article-title":"Conjugated equine estrogens and coronary heart disease","volume":"166","author":"Hsia","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub4-BIB80|cit80","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1359\/jbmr.060312","article-title":"Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the Women's Health Initiative randomized trial","volume":"21","author":"Jackson","year":"2006","journal-title":"Journal of Bone and Mineral Research"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub4-BIB81|cit81","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Health outcomes after stopping conjugated equine esotrogens among postmenopausal women with prior hysterectomy","volume":"305","author":"LaCroix","year":"2011","journal-title":"JAMA"},{"issue":"18","key":"10.1002\/14651858.CD004143.pub4-BIB82|cit82","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1001\/archinternmed.2010.342","article-title":"Postmenopausal hormone use and the risk of nephrolithiasis","volume":"170","author":"Maalouf","year":"2010","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD004143.pub4-BIB83|cit83","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"The New England Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB84|cit84","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1037\/0003-066X.52.2.101","article-title":"Women's Health Initiative: Why now? What is it? What's new?","volume":"52","author":"Matthews","year":"1997","journal-title":"American Psychologist"},{"key":"10.1002\/14651858.CD004143.pub4-BIB85|cit85","unstructured":"National Institutes of Health NIH News: NIH asks participants in Women's Health Initiative estrogen-alone study to stop study pills, begin follow-up phase National Institutes of Health website: www.nih.gov\/news"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub4-BIB86|cit86","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1158\/1055-9965.EPI-08-1209","article-title":"Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study","volume":"18","author":"Prentice","year":"2009","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"20","key":"10.1002\/14651858.CD004143.pub4-BIB87|cit87","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1001\/jama.289.20.2663","article-title":"Effect of estrogen plus progestin on global cognitive function in postmenopausal women","volume":"289","author":"Rapp","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD004143.pub4-BIB88|cit88","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1191\/1740774504cn040oa","article-title":"The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline","volume":"1","author":"Resnick","year":"2004","journal-title":"Clinical Trials"},{"issue":"11","key":"10.1002\/14651858.CD004143.pub4-BIB89|cit89","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1210\/jc.2009-1340","article-title":"Effects of conjugated equine oestrogens on cognition and affect in postmenopausal women with prior hysterectomy","volume":"94","author":"Resnick","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004143.pub4-BIB90|cit90","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1210\/jc.2005-2097","article-title":"Effects of combination estrogen plus progestin hormone treatment on cognition and affect","volume":"91","author":"Resnick","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"10","key":"10.1002\/14651858.CD004143.pub4-BIB91|cit91","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1158\/1055-9965.EPI-08-0385","article-title":"Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial","volume":"17","author":"Ritenbaugh","year":"2008","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub4-BIB92|cit92","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"issue":"24","key":"10.1002\/14651858.CD004143.pub4-BIB93|cit93","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study","volume":"291","author":"Shumaker","year":"2004","journal-title":"JAMA"},{"issue":"20","key":"10.1002\/14651858.CD004143.pub4-BIB94|cit94","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB95|cit95","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S0197-2456(98)00038-5","article-title":"The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of esyrogen therapy in preventing and slowing the progression of dementia","volume":"19","author":"Shumaker","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"14","key":"10.1002\/14651858.CD004143.pub4-BIB96|cit96","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","article-title":"Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy","volume":"295","author":"Stefanick","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB97|cit97","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/S1047-2797(03)00045-0","article-title":"The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants","volume":"13","author":"Stefanick","year":"2003","journal-title":"Annals of Epidemiology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB98|cit98","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/jnci\/djr333","article-title":"Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: Women\u2019s Health Initiative randomized trials","volume":"103","author":"Tang","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"issue":"14","key":"10.1002\/14651858.CD004143.pub4-BIB99|cit99","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB100|cit100","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0197-2456(97)00078-0","article-title":"Design of the Women's Health Initiative clinical trial and observational study","volume":"19","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub4-BIB101|cit101","doi-asserted-by":"publisher","first-page":"211","DOI":"10.7326\/0003-4819-152-4-201002160-00005","article-title":"Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial","volume":"152","author":"Toh","year":"2010","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub4-BIB102|cit102","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/art.23325","article-title":"Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials","volume":"59","author":"Walitt","year":"2008","journal-title":"Arthritis & Rheumatism"},{"issue":"20","key":"10.1002\/14651858.CD004143.pub4-BIB103|cit103","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1001\/jama.289.20.2673","article-title":"Effect of estrogen plus progestin on stroke in postmenopausal women","volume":"289","author":"Wassertheil-Smoller","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB104|cit104","first-page":"321","article-title":"Oestrogen plus progestogen increased coronary heart disease and breast cancer events in postmenopausal women","volume":"288","year":"2002","journal-title":"Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub4-BIB105|cit105","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB106|cit106","first-page":"239","article-title":"Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women","volume":"335","author":"Vickers","year":"2007","journal-title":"BMJ online first"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB107|cit107","first-page":"1","article-title":"The women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial","volume":"7","author":"Vickers","year":"2007","journal-title":"BMC Women's Health"},{"issue":"212","key":"10.1002\/14651858.CD004143.pub4-BIB108|cit108","doi-asserted-by":"publisher","first-page":"a1190","DOI":"10.1136\/bmj.a1190","article-title":"Health related quality of life after combined hormone replacement therapy: randomised controlled trial","volume":"337","author":"Welton","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004143.pub4-BIB109|cit109","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1001\/archneur.63.7.945","article-title":"Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life","volume":"63","author":"Yaffe","year":"2006","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB110|cit110","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1042\/cs0410597","article-title":"The effects of oophorectomy and long-term mestranol therapy therapy on the serum lipids of middle-aged women","volume":"41","author":"Aitken","year":"1971","journal-title":"Clinical Science"},{"key":"10.1002\/14651858.CD004143.pub4-BIB111|cit111","unstructured":"Aitken JM McKay Hart D British Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub4-BIB112|cit112","first-page":"607","article-title":"Prevention of bone loss following oophorectomy in premenopausal women: a retrospective assessment of the effects of oophorectomy and a prospective controlled trial of the effects of mestranol therapy","volume":"12","author":"Aitken","year":"1976","journal-title":"Israel Journal of Medical Sciences"},{"key":"10.1002\/14651858.CD004143.pub4-BIB113|cit113","first-page":"18","article-title":"Long-term oestrogens for the prevention of post-menopausal osteoporosis","volume":"52 Suppl 6","author":"Aitken","year":"1976","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD004143.pub4-BIB114|cit114","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1136\/bmj.3.5879.515","article-title":"Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy","volume":"3","author":"Aitken","year":"1973","journal-title":"British Medical Journal"},{"issue":"7968","key":"10.1002\/14651858.CD004143.pub4-BIB115|cit115","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/S0140-6736(76)92217-0","article-title":"Long-term prevention of postmenopausal osteoporosis by oestrogen","volume":"1","author":"Lindsay","year":"1976","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB116|cit116","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1161\/01.ATV.21.2.262","article-title":"Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: a randomised controlled trial","volume":"21","author":"Angerer","year":"2001","journal-title":"Arteriosclerosis, Thrombosis and Vascular Biology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB117|cit117","first-page":"57","article-title":"Association between target organ responses during hormone replacement therapy","volume":"5 Suppl 1","author":"Bloch Thomsen","year":"2002","journal-title":"Abstracts of posters:10th World Congresss on Menopause, Climacteric"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub4-BIB118|cit118","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/00042192-200109000-00009","article-title":"Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on cardiovascular risk factors","volume":"8","author":"Chen","year":"2001","journal-title":"Menopause: The Journal of the North American Menopause Society"},{"key":"10.1002\/14651858.CD004143.pub4-BIB119|cit119","first-page":"2230","article-title":"Effects of natural oestogen\/gestagen and thiazide on coronary risk factors in normal postmenopausal women: a 2 year double-blind placebo study","volume":"143","author":"Christiansen","year":"1981","journal-title":"Ugeskrift for Laeger"},{"key":"10.1002\/14651858.CD004143.pub4-BIB120|cit120","first-page":"173","article-title":"Effects of the phytoestrogen genistein and hormone replacement therapy on bone mineral density and metabolism in early post-menopausal women: a randomised double blind placebo-controlled study","volume":"5 (Supplement 1","author":"Corrado","year":"2002","journal-title":"Abstracts of Posters: 10th World Congress on Menopause: Climacteric"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub4-BIB121|cit121","first-page":"279","article-title":"Effect of a unique constant-estrogen, pulsed-progestin hormone replacement therapy containing 17-Beta estradiol and norgestimate on endometrial histology","volume":"44","author":"Corson","year":"1999","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD004143.pub4-BIB122|cit122","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1067\/mob.2002.122092","article-title":"Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in health postmenopausal women: Two randomized, placebo-controlled, 2-year studies","volume":"186","author":"Vogelvang","year":"2002","journal-title":"American Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB123|cit123","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1161\/01.ATV.19.12.2993","article-title":"Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: a 2-year placebo-controlled study","volume":"19","author":"Valk-de Roo","year":"1999","journal-title":"Arteriosclerosis, Thrombosis and Vascular Biology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB124|cit124","doi-asserted-by":"publisher","first-page":"191S","DOI":"10.1016\/S8756-3282(96)00266-9","article-title":"Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women","volume":"5 Suppl","author":"Eiken","year":"1996","journal-title":"Bone"},{"key":"10.1002\/14651858.CD004143.pub4-BIB125|cit125","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1001\/archinte.1997.00440430091011","article-title":"Low-dose esterified estrogen therapy","volume":"157","author":"Genant","year":"1997","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD004143.pub4-BIB126|cit126","first-page":"130","article-title":"Low-dose unopposed estrogens: preliminary findings on the frequency and duration of vaginal bleeding in postmenopausal women receiving esterified estrogens over a two-year period","volume":"3","author":"Trabal","year":"4","journal-title":"Menopause: The Journal of the North Amercian Menopause Society"},{"issue":"6","key":"10.1002\/14651858.CD004143.pub4-BIB127|cit127","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00042192-200011000-00002","article-title":"Esterified estrogen therapy in ;postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: a two year study","volume":"7","author":"Watts","year":"2000","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD004143.pub4-BIB128|cit128","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1046\/j.1365-2796.2000.00675.x","article-title":"The EWA (Estrogen in women with atheroscelerosis) Study: a randomized study of the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins","volume":"247","author":"Os","year":"2000","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD004143.pub4-BIB129|cit129","first-page":"579","article-title":"Effect of estrone sulfate on postmenopausal bone loss","volume":"4","author":"Genant","year":"76","journal-title":"Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB130|cit130","first-page":"87","article-title":"Effects of a combination of 2mg estradiol valerate and 3 mg dienogest on coagulation, lipid profile and glucose metabolism in postmenopausal women","volume":"37 Suppl","author":"Graser","year":"2001","journal-title":"Drugs of Today"},{"key":"10.1002\/14651858.CD004143.pub4-BIB131|cit131","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS (hormonal replacement therapy after breast cancer - is it safe?), a randomised comparison: trial stopped","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004143.pub4-BIB132|cit132","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0378-5122(97)00080-7","article-title":"Longterm effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease","volume":"28","author":"Hall","year":"1998","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD004143.pub4-BIB133|cit133","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJM198510173131602","article-title":"Cigarette smoking, serum estrogens and bone loss during hormone-replacement therapy early after menopause","volume":"313","author":"Jensen","year":"1985","journal-title":"the New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004143.pub4-BIB134|cit134","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0378-5122(98)00085-1","article-title":"HRT and vit D in prevention of non-vertebral fractures in postmenopausal women: a 5 year randomized trial","volume":"31","author":"Komulainen","year":"1998","journal-title":"Maturitas"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub4-BIB135|cit135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-117-1-1","article-title":"Treatment of postmenopausal osteoporosis with transdermal estrogen","volume":"117","author":"Lufkin","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004143.pub4-BIB136|cit136","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0197-4580(04)80357-9","article-title":"Changes in self-reported personality coincident with declines in cognition: results from parallel hormone therapy trials in elderly men and women","volume":"25 Suppl 2","author":"Maki","year":"2004","journal-title":"NeuroBiology of Aging"},{"key":"10.1002\/14651858.CD004143.pub4-BIB137|cit137","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/13697130902926910","article-title":"Dose effects of oral estradiol on bone mineral density in Japanese women with osteoporosis","volume":"13","author":"Mizunuma","year":"2010","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD004143.pub4-BIB138|cit138","unstructured":"Newhouse 2000 Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer Disease Clinical trials.gov.2003"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB139|cit139","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1447-0756.1993.tb00360.x","article-title":"Estradiol administered in a percutaneous gel for the prevention of postmenopausal bone loss","volume":"19","author":"Ng","year":"1993","journal-title":"Asia-Oceania Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB140|cit140","doi-asserted-by":"publisher","first-page":"735","DOI":"10.4065\/73.8.735","article-title":"Effects of long-term transdermal administration of estradiol on serum lipids","volume":"73","author":"Ory","year":"1998","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD004143.pub4-BIB141|cit141","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000064667","article-title":"Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease","volume":"98","author":"Os","year":"2002","journal-title":"Cardiology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB142|cit142","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/j.1471-0528.2002.01544.x","article-title":"A study of hormone-replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study","volume":"109","author":"Clarke","year":"2002","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB143|cit143","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1067\/mob.2001.117340","article-title":"Raloxifene reduces impedance to flow within the uterine artery in early postmenopausal women: A 2-year randomized placebo-controlled comparative study","volume":"185","author":"Post","year":"2001","journal-title":"American Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB144|cit144","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1067\/mob.2002.122092","article-title":"Neither long-term treatment with raloxifene nor hormone replacement therapy modulate cardiac function in health postmenopausal women: Two randomized, placebo-controlled, 2-year studies","volume":"186","author":"Vogelvang","year":"2002","journal-title":"American Journal of Obstetrics and Gynaecology"},{"issue":"9","key":"10.1002\/14651858.CD004143.pub4-BIB145|cit145","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1161\/hq0901.095565","article-title":"Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vaso-dilation in postmenopausal women","volume":"21","author":"Saitta","year":"2001","journal-title":"Arteriosclerosis, Thrombosis and Vascular Biology"},{"issue":"9","key":"10.1002\/14651858.CD004143.pub4-BIB146|cit146","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1002\/art.22855","article-title":"Menopause hormonal therapy in women with systemic lupus erythematosus","volume":"56","author":"Sanchez-Guerrero","year":"2007","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD004143.pub4-BIB147|cit147","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/01.AOG.0000251518.56369.eb","article-title":"Unoppposed estradiol therapy in postmenopausal women","volume":"109","author":"Steiner","year":"2007","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB148|cit148","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/cmt.5.2.160.169","article-title":"Placebo-controlled trial of transdermal estrogen therapy alone in postmenopausal women: effects on arterial compliance and endothelial function","volume":"5","author":"Teede","year":"2002","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD004143.pub4-BIB149|cit149","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/01.gme.0000192439.82491.24","article-title":"Effects of ultralow-dose transdermal estradion on postmenopausal symptoms in women aged 60 to 80 years","volume":"1","author":"Diem","year":"2006","journal-title":"Menopause"},{"key":"10.1002\/14651858.CD004143.pub4-BIB150|cit150","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1097\/01.AOG.0000182576.48290.6d","article-title":"The effect of ultralow-dose transdermal estradion on urinary incontinence in potmenopausal women","volume":"1","author":"Waetjen","year":"2005","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB151|cit151","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1471-0528.1999.tb08216.x","article-title":"Climacteric vasomotor symptoms do not imply autonomic dysfunction","volume":"106","author":"Virtanen","year":"1999","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB152|cit152","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-2011-110341","article-title":"Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial","volume":"26","author":"Wharton","year":"2011","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1002\/14651858.CD004143.pub4-BIB153|cit153","unstructured":"Australian Menopause Society AMS guide to equivalent HRT doses www.menopause.org.au 2009"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub4-BIB154|cit154","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":"Effects of Estrogen plus progestin on gynecologic cancers and associated diagnostic procedures","volume":"290","author":"Anderson","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB155|cit155","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.maturitas.2006.05.004","article-title":"Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin","volume":"55","author":"Anderson","year":"2006","journal-title":"Maturitas"},{"key":"10.1002\/14651858.CD004143.pub4-BIB156|cit156","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0277-9536(00)00147-7","article-title":"Is there a menopausal syndrome? Menopausal status and symptoms across racial\/ethnic groups","volume":"52","author":"Avis","year":"2001","journal-title":"Social Science and Medicine"},{"issue":"11","key":"10.1002\/14651858.CD004143.pub4-BIB157|cit157","doi-asserted-by":"publisher","first-page":"e1000181","DOI":"10.1371\/journal.pmed.1000181","article-title":"Hip fracture incidence in relation to age, menopausal status, and age at menopause: prospective analysis","volume":"6","author":"Banks","year":"2009","journal-title":"PLoS Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub4-BIB158|cit158","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/aje\/kwm214","article-title":"Hormones and heart disease: the timing hypothesis","volume":"166","author":"Barrett-Connor","year":"2007","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB159|cit159","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev.publhealth.19.1.55","article-title":"HOrmone replacement therapy, heart disease and other considerations","volume":"19","author":"Barrett-Connor","year":"1998","journal-title":"Annual Review of Public Health"},{"key":"10.1002\/14651858.CD004143.pub4-BIB160|cit160","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/ije\/30.3.423","article-title":"Hormone replacement therapy (HRT) - risks and benefits","volume":"30","author":"Barrett-Connor","year":"2001","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB161|cit161","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/bmj.38331.655347.8F","article-title":"Association between hormone replacement therapy and subsequent stroke: a meta-analysis","volume":"330","author":"Bath","year":"2005","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004143.pub4-BIB162|cit162","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(02)11032-4","article-title":"Evidence from randomised trials on the long-term effects of hormone replacement therapy","volume":"360","author":"Beral","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004143.pub4-BIB163|cit163","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004143.pub4-BIB164|cit164","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/jnci\/djq527","article-title":"Breast cancer risk in relation to the interval between menopause and starting hormone therapy","volume":"103","author":"Beral","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub4-BIB165|cit165","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub4-BIB166|cit166","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB167|cit167","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(04)15519-0","article-title":"Menopausal hormone therapy after breast cancer","volume":"363","author":"Chlebowski","year":"2004","journal-title":"The Lancet"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub4-BIB168|cit168","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archinternmed.2007.123","article-title":"Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy","volume":"168","author":"Chlebowski","year":"2008","journal-title":"Archives of Internal Medicine"},{"issue":"9697","key":"10.1002\/14651858.CD004143.pub4-BIB169|cit169","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0140-6736(09)61526-9","article-title":"Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial","volume":"374","author":"Chlebowski","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004143.pub4-BIB170|cit170","first-page":"3","article-title":"Breast cancer after use of estrogen plus progestin in postmenopausal women","volume":"57","author":"Chlebowski","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"10.1002\/14651858.CD004143.pub4-BIB171|cit171","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1001\/jama.2010.1500","article-title":"Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women","volume":"304","author":"Chlebowski","year":"2010","journal-title":"Jama"},{"key":"10.1002\/14651858.CD004143.pub4-BIB172|cit172","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1200\/JCO.2009.24.8799","article-title":"Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy","volume":"28","author":"Chlebowski","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"18","key":"10.1002\/14651858.CD004143.pub4-BIB173|cit173","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/jnci\/djq285","article-title":"Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial","volume":"102","author":"Chlebowski","year":"2010","journal-title":"Journal of the National Cancer Institute"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub4-BIB174|cit174","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001405.pub2","article-title":"Oestrogen therapy for urinary incontinence in post-menopausal women","author":"Cody","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub4-BIB175|cit175","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1210\/er.2001-9002","article-title":"Summary of meta-analyses of therapies for postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocrine Reviews"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub4-BIB176|cit176","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"issue":"24","key":"10.1002\/14651858.CD004143.pub4-BIB177|cit177","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1001\/jama.291.24.2959","article-title":"Conjugated equine estrogens and global cognitive function in postmenopausal women","volume":"291","author":"Espeland","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB178|cit178","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000402.pub3","article-title":"Hormone therapy in postmenopausal women and risk of endometrial hyperplasia","author":"Furness","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB179|cit179","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","article-title":"Hormone replacement therapy and endometrial cancer risk: a meta-analysis","volume":"85","author":"Grady","year":"1995","journal-title":"Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB180|cit180","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(98)05352-5","article-title":"The menopause","volume":"353","author":"Greendale","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub4-BIB181|cit181","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/humupd\/dmm012","article-title":"Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis","volume":"13","author":"Greiser","year":"2007","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD004143.pub4-BIB182|cit182","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1013::AID-CNCR17>3.0.CO;2-1","article-title":"Estrogen replacement for ovarian cancer survivors: a randomized controlled trial","volume":"86","author":"Guidozzi","year":"1999","journal-title":"Cancer"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub4-BIB183|cit183","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/01.GME.0000155200.80687.BE","article-title":"Hot flushes during the menopause transition: a longitudinal study in Australian-born women","volume":"12","author":"Guthrie","year":"2005","journal-title":"Menopause"},{"issue":"9","key":"10.1002\/14651858.CD004143.pub4-BIB184|cit184","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1001\/jama.299.9.1036","article-title":"Health risks and benefit 3 years after stopping randomized treatment with estrogen and progestin","volume":"299","author":"Heiss","year":"2008","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB185|cit185","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/bmj.315.7101.149","article-title":"Impact of post menopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials","volume":"315","author":"Hemminki","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004143.pub4-BIB186|cit186","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0140-6736(99)03432-7","article-title":"Value of drug-licensing documents in studying the effect of postmenopausal hormone therapy on cardiovascular disease","volume":"355","author":"Hemminki","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004143.pub4-BIB187|cit187","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/140349480002800201","article-title":"Hormone replacement therapy: discrepancies between evidence and recommendations","volume":"28","author":"Hemminki","year":"2000","journal-title":"Scandinavian Journal of Public Health"},{"key":"10.1002\/14651858.CD004143.pub4-BIB188|cit188","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1161\/CIRCULATIONAHA.105.594077","article-title":"Effects of conjugated equine estrogen on stroke in the Women's Health Initiative","volume":"113","author":"Hendrix","year":"2006","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD004143.pub4-BIB189|cit189","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004143.pub4-BIB190|cit190","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011 ] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub4-BIB191|cit191","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003799.pub2","article-title":"Hormone replacement therapy to maintain cognitive function in women with dementia","author":"Hogervorst","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004143.pub4-BIB192|cit192","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS (hormonal replacement therapy after breast cancer - is it safe?), a randomised comparison: trial stopped","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD004143.pub4-BIB193|cit193","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":"Increased risk of recurrence after hormone replacement therapy in breast cancer survivors","volume":"100","author":"Holmberg","year":"2008","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD004143.pub4-BIB194|cit194","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1001\/jama.291.14.1769","article-title":"The WHI estrogen-alone trial - do things look any better?","volume":"291","author":"Hulley","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB195|cit195","unstructured":"Institute of Cancer Research UK Randomised Trial of Hormone Replacement Therapy (HRT) in Women with a History of Early Breast Cancer UK Randomised Trial of Hormone Replacement Therapy (HRT) in Women with a History of Early Breast Cancer Online at: http:\/\/www.icr.ac.uk\/ctsu\/hrt.htm"},{"issue":"9","key":"10.1002\/14651858.CD004143.pub4-BIB196|cit196","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007063.pub2","article-title":"Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women","author":"Ismail","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004143.pub4-BIB197|cit197","unstructured":"Kaunitz AM Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative Medscape Women's Health e-journal at: http:\/\/medscape.com 2002"},{"issue":"3","key":"10.1002\/14651858.CD004143.pub4-BIB198|cit198","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001018","article-title":"Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution","author":"Kongnyuy","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3\/4","key":"10.1002\/14651858.CD004143.pub4-BIB199|cit199","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0531-5565(94)90012-4","article-title":"Hot flashes:phenomenology, quality of life and search for treatment options","volume":"29","author":"Kronenberg","year":"1994","journal-title":"Experimental Gerontology"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB200|cit200","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"issue":"13","key":"10.1002\/14651858.CD004143.pub4-BIB201|cit201","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1001\/jama.2011.382","article-title":"Health outcomes after stopping conjugated equine esotrogens among postmenopausal women with prior hysterectomy","volume":"305","author":"LaCroix","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub4-BIB202|cit202","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003122.pub2","article-title":"Hormone replacement therapy for cognitive function in postmenopausal women","author":"Lethaby","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub4-BIB203|cit203","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002978.pub2","article-title":"Oral oestrogen and combined oestrogen\/progestogen therapy versus placebo for hot flushes","author":"MacLennan","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004143.pub4-BIB204|cit204","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women","volume":"349","author":"Manson","year":"2003","journal-title":"The New England Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB205|cit205","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1037\/0003-066X.52.2.101","article-title":"Women's Health Initiative: Why now? What is it? What's new?","volume":"52","author":"Matthews","year":"1997","journal-title":"American Psychologist"},{"issue":"1","key":"10.1002\/14651858.CD004143.pub4-BIB206|cit206","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2165\/00003495-199856010-00005","article-title":"A practical guide to prescribing hormone replacement therapy","volume":"56","author":"McKinney","year":"1998","journal-title":"Drugs"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB207|cit207","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/gme.0b013e3181d0f6b9","article-title":"Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.","volume":"17","year":"2010","journal-title":"Menopause\u00a0"},{"key":"10.1002\/14651858.CD004143.pub4-BIB208|cit208","unstructured":"National Institutes of Health NIH News: NIH asks participants in Women's Health Initiative estrogen-alone study to stop study pills, begin follow-up phase National Institutes of Health website: www.nih.gov\/news"},{"issue":"11","key":"10.1002\/14651858.CD004143.pub4-BIB209|cit209","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1093\/humrep\/deg435","article-title":"Issues to debate on the Women's Health Initiative (WHI) study. Epidemiology or randomized clinical trials-time out for hormone replacement therapy studies?","volume":"18","author":"Pedersen","year":"2003","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD004143.pub4-BIB210|cit210","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1158\/1055-9965.EPI-08-1209","article-title":"Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study","volume":"18","author":"Prentice","year":"2009","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1002\/14651858.CD004143.pub4-BIB211|cit211","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/aje\/kwp115","article-title":"Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause","volume":"170","author":"Prentice","year":"2009","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004143.pub4-BIB212|cit212","unstructured":"The Royal Australian and New Zealand College of Obstetricians and Gynaecologists Management of the menopause (C-Gyn 9) http:\/\/www.ranzcog.edu.au\/womens-health\/statements-a-guidelines\/new-a-revised-statements-and-guidelines\/469-management-of-the-menopause-c-gyn-9.html 2011"},{"key":"10.1002\/14651858.CD004143.pub4-BIB213|cit213","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1191\/1740774504cn040oa","article-title":"The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline","volume":"1","author":"Resnick","year":"2004","journal-title":"Clinical Trials"},{"key":"10.1002\/14651858.CD004143.pub4-BIB214|cit214","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1210\/jc.2005-2097","article-title":"Effects of combination estrogen plus progestin hormone treatment on cognition and affect","volume":"91","author":"Resnick","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004143.pub4-BIB215|cit215","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/j.1525-1497.2004.30281.x","article-title":"Mortality associated with hormone replacement therapy in younger and older women","volume":"19","author":"Salpeter","year":"2004","journal-title":"Journal of General Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB216|cit216","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002229.pub2","article-title":"Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women","author":"Gabriel S\u00e1nchez","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004143.pub4-BIB217|cit217","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1080\/cmt.6.4.302.313","article-title":"Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial","volume":"6","author":"Shapiro","year":"2003","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD004143.pub4-BIB218|cit218","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S0197-2456(98)00038-5","article-title":"The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of esyrogen therapy in preventing and slowing the progression of dementia","volume":"19","author":"Shumaker","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"24","key":"10.1002\/14651858.CD004143.pub4-BIB219|cit219","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study","volume":"291","author":"Shumaker","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004143.pub4-BIB220|cit220","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/S1047-2797(03)00045-0","article-title":"The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants","volume":"13","author":"Stefanick","year":"2003","journal-title":"Annals of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD004143.pub4-BIB221|cit221","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001500.pub2","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","author":"Suckling","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004143.pub4-BIB222|cit222","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1210\/jc.2010-0536","article-title":"Update in Hormone Therapy Use in Menopause","volume":"96","author":"Taylor","year":"2011","journal-title":"Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD004143.pub4-BIB223|cit223","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1080\/cmt.6.4.302.313","article-title":"Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized trial: comments from reviewer","volume":"6","author":"Tucker","year":"2003","journal-title":"Climacteric"},{"key":"10.1002\/14651858.CD004143.pub4-BIB224|cit224","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in health postmenopausal women: principal results from the Women's Health Initiative randomised controlled trial","volume":"288","year":"2002","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004143.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T00:00:00Z","timestamp":1484611200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004143.pub4\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:30:51Z","timestamp":1628544651000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004143.pub4"}},"subtitle":[],"editor":[{"given":"Cindy","family":"Farquhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,11]]},"references-count":224,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004143.pub4","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004143.pub5","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2012,7,11]]}}}